<PAGE>
Securities Exchange Act of 1934--Form 8-K B-2-5
================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) March 7, 1997
--------------------------------
INTERACTIVE MEDICAL TECHNOLOGIES LTD.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-21384 13-3367421
- ---------------------------- ------------------ ---------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number)* Identification No.)
1717 Stewart Street Santa Monica, California 90404
- ---------------------------------------------------- ------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: 310 586-5555
-------- -----------
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
================================================================================
*This is the file number assigned by the Commission under the Securities
Exchange Act of 1934 and not the file number of registration statements filed
under the Securities Act of 1933. (Editor)
<PAGE>
Item 5. Other Material Events
During the month of March, 1997, the Registrant concluded four (4)
separate issuances of its Convertible Debentures to non-U.S. persons pursuant to
the provisions of Regulation S. These Convertible Debentures, in the face
amounts of $85,000, $17,000, $10,000 and $5,000, respectively, each have a term
of 365 days and are convertible at any time at the option of the holder at a
conversion price to be calculated by applying a 35% discount to the average bid
price of the Registrant's common stock for a five (5) day period immediately
prior to conversion, with a floor of $.08 and a ceiling of $.14 per share.
In addition, also during the month of March, 1997, the Registrant
sold, to Credit Suisse, a total of 5,000,000 of its common shares at $.09 per
share and warrants to purchase an additional 3,000,000 common shares at an
exercise price of $.09 per share for total consideration of $450,000. This
transaction was effected pursuant to the terms and conditions of Regulation S.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
INTERACTIVE MEDICAL TECHNOLOGIES LTD.
-------------------------------------
(Registrant)
/s/ Peter Benz
-------------------------------------
(Signature)
Peter Benz, President
- ---------------------
Print name and title of signing officer.
Date April 14, 1997
---------------
